Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma)

Authors :: Zinzani, Pl
Derenzini, E
Pellegrini, C
Rigacci, L
Fabbri, A
Gandolfi, L
Argnani, L
Casadei, B
Pulsoni, A
Gobbi, M
Perotti, A
Zaccaria, A
Voso, Maria Teresa
Cabras, Mg
De Renzo, A.
Zinzani, Pl
Derenzini, E
Pellegrini, C
Rigacci, L
Fabbri, A
Gandolfi, L
Argnani, L
Casadei, B
Pulsoni, A
Gobbi, M
Perotti, A
Zaccaria, A
Voso, Maria Teresa
Cabras, Mg
De Renzo, A.
Publication Year :: 2012
Abstract: No abstract

Tools